| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Sialomucin core protein 24, MUC-24, Endolyn, Multi-glycosylated core protein 24, MGC-24, MGC-24v, CD164, CD164 |
| Entrez GeneID | 8763 |
| WB Predicted band size | 20.9kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse, Rat |
| Immunogen | This CD164 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 152-185 amino acids from the C-terminal region of human CD164. |
+ +
以下是关于CD164抗体的3篇参考文献的简要概括：
---
1. **文献名称**：*CD164 is a novel prognostic marker in colorectal cancer associated with tumor cell migration and invasion*
**作者**：Liu Y, et al.
**摘要**：该研究通过免疫组织化学实验分析CD164在结直肠癌组织中的表达，发现其高表达与患者预后不良相关。CD164抗体用于检测肿瘤细胞表面标记，揭示其通过调控细胞迁移和侵袭促进癌症进展的机制。
---
2. **文献名称**：*CD164 modulates the CXCL12-mediated migration of hematopoietic stem/progenitor cells*
**作者**：Watt SM, et al.
**摘要**：研究利用CD164特异性抗体阻断实验，证明CD164通过调控CXCL12/CXCR4信号通路影响造血干细胞(HSC)的迁移和归巢功能，为干细胞治疗提供潜在靶点。
---
3. **文献名称**：*CD164 antibody-targeted nanoparticles for selective delivery to hematopoietic stem cells*
**作者**：Lee JH, et al.
**摘要**：该文献开发了一种基于CD164抗体的靶向纳米载体，用于高效递送药物至造血干细胞。实验表明，CD164抗体可特异性识别并富集干细胞群体，提高靶向治疗的精准度。
---
**备注**：以上文献为示例，实际引用时需核对具体发表信息及数据库(如PubMed、Web of Science)。如需进一步扩展，建议结合近期研究筛选高影响力论文。
CD164. also known as endolyn or multi-glycosylated core protein 24. is a cell surface sialomucin expressed in hematopoietic stem/progenitor cells, endothelial cells, and epithelial tissues. It plays critical roles in cell adhesion, migration, proliferation, and differentiation by modulating interactions with extracellular matrix components and signaling pathways. CD164 antibodies are immunological tools designed to target specific epitopes on the CD164 protein, enabling researchers to study its expression patterns, functional mechanisms, and therapeutic potential.
These antibodies are widely used in flow cytometry, immunohistochemistry, and Western blotting to investigate CD164's involvement in physiological processes like hematopoietic stem cell maintenance, immune regulation, and tissue repair. In disease contexts, CD164 has been implicated in cancer progression (e.g., leukemia, breast, and prostate cancers) due to its role in promoting cell survival and metastasis. CD164 antibodies help identify its overexpression in tumor tissues, correlate it with clinical outcomes, and explore its utility as a diagnostic or prognostic biomarker.
Structurally, CD164 contains leucine-rich repeats and mucin-like domains, enabling interactions with receptors such as CXCR4. CD164 antibodies have also been applied in functional studies to block these interactions, revealing insights into pathways like PI3K/AKT and MAPK. Their therapeutic potential is being explored in targeting cancer stem cells or disrupting pathogenic signaling in inflammatory disorders. Both monoclonal and polyclonal CD164 antibodies are commercially available, validated for specificity across human and murine models.
×
